SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-162772
Filing Date
2021-05-17
Accepted
2021-05-17 07:36:03
Documents
6

Document Format Files

Seq Description Document Type Size
1 8-K d120588d8k.htm DEFA14A 53686
2 EX-2.1 d120588dex21.htm EX-2.1 870619
3 EX-3.1 d120588dex31.htm EX-3.1 3303
4 EX-10.1 d120588dex101.htm EX-10.1 406418
5 EX-99.1 d120588dex991.htm EX-99.1 30041
6 GRAPHIC g120588g0517105617913.jpg GRAPHIC 4685
  Complete submission text file 0001193125-21-162772.txt   1371730
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38560 | Film No.: 21927569
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences